These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 33351863)
41. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus. Fadaka AO; Sibuyi NRS; Martin DR; Goboza M; Klein A; Madiehe AM; Meyer M Sci Rep; 2021 Oct; 11(1):19707. PubMed ID: 34611250 [TBL] [Abstract][Full Text] [Related]
42. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches. Dong R; Chu Z; Yu F; Zha Y Front Immunol; 2020; 11():1784. PubMed ID: 32849643 [TBL] [Abstract][Full Text] [Related]
43. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets. Oliveira SC; de Magalhães MTQ; Homan EJ Front Immunol; 2020; 11():587615. PubMed ID: 33193414 [TBL] [Abstract][Full Text] [Related]
45. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2. Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045 [TBL] [Abstract][Full Text] [Related]
46. Design of multi-epitope chimeric vaccine against Monkeypox virus and SARS-CoV-2: A vaccinomics perspective. Al-Madhagi H; Kanawati A; Tahan Z J Cell Mol Med; 2024 May; 28(10):e18452. PubMed ID: 38801408 [TBL] [Abstract][Full Text] [Related]
47. MERS virus spike protein HTL-epitopes selection and multi-epitope vaccine design using computational biology. Joshi A; Akhtar N; Sharma NR; Kaushik V; Borkotoky S J Biomol Struct Dyn; 2023; 41(22):12464-12479. PubMed ID: 36935104 [TBL] [Abstract][Full Text] [Related]
48. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2. Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372 [TBL] [Abstract][Full Text] [Related]
49. Design of a multi-epitope-based vaccine consisted of immunodominant epitopes of structural proteins of SARS-CoV-2 using immunoinformatics approach. Mahmoudvand S; Esmaeili Gouvarchin Ghaleh H; Jalilian FA; Farzanehpour M; Dorostkar R Biotechnol Appl Biochem; 2023 Jun; 70(3):1189-1205. PubMed ID: 36577011 [TBL] [Abstract][Full Text] [Related]
50. Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation. Srivastava S; Verma S; Kamthania M; Kaur R; Badyal RK; Saxena AK; Shin HJ; Kolbe M; Pandey KC JMIR Bioinform Biotechnol; 2020; 1(1):e19371. PubMed ID: 32776022 [TBL] [Abstract][Full Text] [Related]
51. Construction and efficacy testing of DNA vaccines containing HLA-A*02:01-restricted SARS-CoV-2 T-cell epitopes predicted by immunoinformatics. Tan D; Kang N; Zhu Y; Hou J; Wang H; Xu H; Zu C; Gao Z; Liu M; Liu N; Deng Q; Lu H; Liu J; Xie Y Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(7):986-996. PubMed ID: 38655616 [TBL] [Abstract][Full Text] [Related]
52. Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches. Abbasi BA; Saraf D; Sharma T; Sinha R; Singh S; Sood S; Gupta P; Gupta A; Mishra K; Kumari P; Rawal K PeerJ; 2022; 10():e13380. PubMed ID: 35611169 [TBL] [Abstract][Full Text] [Related]
53. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus. Singh J; Malik D; Raina A Vaccine; 2021 Feb; 39(7):1087-1095. PubMed ID: 33478787 [TBL] [Abstract][Full Text] [Related]
54. Epitope-Based Potential Vaccine Candidate for Humoral and Cell-Mediated Immunity to Combat Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic. Das BK; Chakraborty D J Phys Chem Lett; 2020 Nov; 11(22):9920-9930. PubMed ID: 33174418 [TBL] [Abstract][Full Text] [Related]
55. Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay. Polyiam K; Phoolcharoen W; Butkhot N; Srisaowakarn C; Thitithanyanont A; Auewarakul P; Hoonsuwan T; Ruengjitchatchawalya M; Mekvichitsaeng P; Roshorm YM Sci Rep; 2021 Oct; 11(1):20383. PubMed ID: 34650130 [TBL] [Abstract][Full Text] [Related]
56. In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine. Shehata MM; Mahmoud SH; Tarek M; Al-Karmalawy AA; Mahmoud A; Mostafa A; M Elhefnawi M; Ali MA Molecules; 2021 Oct; 26(20):. PubMed ID: 34684763 [TBL] [Abstract][Full Text] [Related]
57. Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern. Martín-Galiano AJ; Díez-Fuertes F; McConnell MJ; López D Front Immunol; 2021; 12():732693. PubMed ID: 34899692 [TBL] [Abstract][Full Text] [Related]
58. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2). Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882 [TBL] [Abstract][Full Text] [Related]
59. Coevolution based immunoinformatics approach considering variability of epitopes to combat different strains: A case study using spike protein of SARS-CoV-2. Mishra SK; Priya P; Rai GP; Haque R; Shanker A Comput Biol Med; 2023 Sep; 163():107233. PubMed ID: 37422941 [TBL] [Abstract][Full Text] [Related]